Skip to content

An observational study to evaluate the efficacy of suturing mucosal defects post duodenal endoscopic submucosal dissection

An observational study to evaluate the efficacy of suturing mucosal defects post duodenal endoscopic submucosal dissection - Suturing study post duodenal ESD

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000050513
Enrollment
220
Registered
2023-03-07
Start date
2023-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

superficial non-ampullary duodenal epithelial tumor

Interventions

None listed

Sponsors

Keio University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1)The lesion is located anal side than descending part of duodenum (lesions crossing the superior duodenal angle can be included). (2)The lesion size is less than 50 mm at preoperative evaluation. (3)Endoscopically suspected adenoma or adenocarcinoma (preoperative biopsy not required) (4)No endoscopic findings suggestive of submucosal invasion (5)Patients aged 20 to 85 years at the time of obtaining consent (6)Patients who give written consent to participate in this study

Exclusion criteria

Exclusion criteria: (1) Patients with familial adenomatous polyposis (FAP) (2) Patients who are treated for multiple lesions at the same time (patients with multiple lesions, including those of other organs, can be included if only one lesion is treated during the protocol treatment period) (3) Patients with history of duodenal resection in the past (4) Patients with a distance of 10 mm or less between the lesion and the duodenal papilla or accessory papilla (5) Patients whose lesions involve the duodenal bulb on the oral side (6) Vital organ insufficiency (heart, lung, liver, kidney, bone marrow) (7) Patients who cannot be managed perioperatively with antithrombotic drugs according to the guidelines proposed by Japan Gastroenterological Endoscopy Society (8) Other patients considered by the attending physician to be ineligible for entry

Design outcomes

Primary

MeasureTime frame
Rate of delayed adverse events (bleeding, perforation) within 28 days postoperatively

Secondary

MeasureTime frame
(1) Postoperative outcomes rate of delayed bleeding rate of delayed perforation rate of surgery due to adverse events rate of maintenance of complete sutures and the number of remaining clips at the second-look endoscopy 3-5 days after surgery (2) Healthcare economics length of hospital stay total medical cost of hospitalization

Countries

Japan

Contacts

Public ContactKurato Miyazaki

Keio University School of Medicine Division of Gastroenterology and Hepatology, Department of Internal Medicine

k.miyazaki30417@gmail.com03-3353-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026